Extracts of St. John's wort for mild to moderate depression - A meta-analysis of randomized, double-blinded and placebo-controlled trials

Nutritional Sciences Journal

Volumn 30, Issue 4, 2005, Pages 166-173

  Jou, Hei Jen ^a,b   Hsu, I Ping ^c   Ling, Pei Ying ^a   Huang, Hui Ting ^a   Lin, Chia Tzu ^a   Wu, Shiao Chi ^d  

^a TAIWAN ADVENTIST HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alternative medicine; Depression; St. John's wort

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; HYPERICUM PERFORATUM; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYSTEMATIC REVIEW;

EID: 33751258272     PISSN: 10116958     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU and Kendler KS. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
2. Pan HA, Wu MH, Hsu CC, Yao BL and Huang KE. (2002) The perception of menopause among women in Taiwan. Maturitas. 41:269-274.
3. Chow SN, Huang CC and Lee YT. (1997) Demographic characteristics and medical aspects of menopausal women in Taiwan. J Formos Med Assoc 96:806-811.
4. Lawvere S, Mahoney MC. (2005) St. John's wort. Am Fam Physician 72:2249-2254.
5. Hansgen KD, Vesper J and Ploch M. (1994) Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. J Geriatr Psychiatry Neurol 7 Suppl. 1:S15-S18.
6. Sommer H and Harrer G. (1994) Placebo-controlled double-blind study examining the effectiveness of a hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 7 Suppl. 1:S9-S11.
7. Hubner WD, Lande S and Podzuweit H. (1994) Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol 7 Suppl. 1:S12-S14.
8. Laakmann G, Schule C, Baghai T and Kieser M. (1998) St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 31 Suppl. 1:S54-S59.
9. Philipp M, Kohnen R and Miller KO. (1999) Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 319:1534-1538.
10. Kalb R, Trautmann-Sponsel RD and Kieser M. (2001) Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 4:96-103.
11. Lecrubier Y, Clerc G, Didi R and Kieser M. (2002) Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 159:1361-1366.
12. Uebelhack R, Gruenwald J, Graubaum H and Busch R. (2004) Efficacy and tolerability of hypericum extract STW3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial. Adv Ther 21:265-275.
13. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, and Halbreich U. (2001) Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 285:1978-1986.
14. Hypericum Depression Trial Study Group. (2002) Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA 287:1807-1814.
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ and McQuay HJ. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12.
16. Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56-62.
17. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005). http://www.cochrane.org/resources/ handbook/ hbook.htm (accessed 31st May 2005).
18. Rosner B. (2000) Design and analysis techniques for epidemiology studies. In 5 th Edi. Fundamentals of Biostatics. pp.577-676. Duxbury press, CA.
19. Nahrstedt A and Butterweck V. (1997) Biologically active and other chemical constituents of the herb Hypericum perforatum L. Pharmacopsychiatry 30 suppl. 2:129-134.
20. Jurgenliemk G and Nahrstedt A. (2002) Phenolic compounds from Hypericum perforatum. Plant Med 68:88-91.
21. Butterweck V. (2003) Mechanism of action of St John's wort in depression: what is known? CNS Drugs 17:539-562.
22. Flind MP. (2003) Complementary and alternative medicines and menopause. Menopause 10:491-493.
23. http://nccam.nih.gov/ 2005/11/15
24. Greeson JM, Sanford B, Monti DA. (2001) St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl) 153:402-14.